Drug Type Small molecule drug |
Synonyms Rho kinase inhibnitors(CHDI Foundation) |
Target |
Mechanism Huntingtin inhibitors, ROCK2 inhibitors(Rho-associated protein kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Huntington Disease | Preclinical | US | - |